Loading clinical trials...
Loading clinical trials...
Assessing the Effects of an In-office, Language-concordant App on Eye Drop Recall in Patients With Multi-drop Regimens
The goal of this interventional study is to assess whether an in-office, language-concordant instructional app improves drop regimen recall in a population of glaucoma patients who are on multi-drop regimens. Participants will be divided into two groups -- those who use the app and those who do not. The app will have narrated information regarding the drop regimen, a quiz to test understanding of the regimen, and will enable a graphical printout of the eye drops and schedule. At one month, both groups will be assessed on their eye drop regimen recall.
Specific Aim: To investigate whether a language-concordant instructional application improves drop regimen recall in population of glaucoma patients at a 1-month follow-up period. App features 1. Pictorial representation of drops (color-coded) and schedule. 2. Quiz to assess understanding of the regimen. 3. Narrated instructions (language-concordant) on how and when (frequency and eye laterality) to take each drop. 4. Graphical print-out of the regimen. Study design 1. Study design: Randomized study, two groups: (1) patients that use the app, and (2) patients that do not use the app. 2. Study population: Inclusion criteria: patients with primary open-angle glaucoma on at least 2 eye drops Exclusion criteria: patients taking additional prescribed eye drops for other eye conditions; patients diagnosed within the last 3 months; patients unable to self-administer eye drops 3. Intervention: Use of an in-office app that has both graphical and verbal (language-concordant) instruction for how to use drops. 4. Main outcome measure: Ability to correctly identify drops/regimen
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
San Francisco General Hospital
San Francisco, California, United States
Start Date
September 1, 2024
Primary Completion Date
June 1, 2025
Completion Date
June 1, 2025
Last Updated
December 30, 2025
20
ACTUAL participants
App
OTHER
Lead Sponsor
University of California, San Francisco
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07396441